REVIEW Acebutolol is a selective β1-receptor antagonist used for the treatment of hypertension. It blocks the activation of β1-receptors by epinephrine, which would increases heart rate and blood pressure. Beta blockers also prevent the release of renin, a hormone secreted by the kidneys which leads to constriction of blood vessels.
Wooldridge, K. R. H New cardioselective beta-adrenoceptor blocking agent Experientia (1972), 28(12), 1404.
Basil, B.; Clark, J. R.; Coffee, E. C. J.; Jordan, R.; Loveless, A. H.; Pain, D. L.; Wooldridge, K. R. H. New series of cardioselective adrenergic beta-receptor blocking compounds. 1-(2-Acyl-4-acylaminophenoxy)-3-isopropylaminopropan-2-ols Journal of Medicinal Chemistry (1976), 19(3), 399-402.
De Bono G, Kaye CM, Roland E, Summers AJ.Acebutolol: ten years of experience. Am Heart J. 1985 May;109(5 Pt 2):1211-3.
Singh BN, Thoden WR, Ward A. Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia. Drugs. 1985 Jun;29(6):531-69.
These chemical products are for research and development use only. They are not for diagnostic, therapeutic, cosmetic, or human and animal uses. They are not sold to individuals. Additional restrictions may apply.
New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. CATEGORIES APIs and Bioactives > Beta Blockers